Toshiyuki Kozuki
Nankoku, 7838505, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 108 publications
Final overall survival analysis of the APPLE study: atezolizumab and platinum-pemetrexed with or without bevacizumab for metastatic nonsquamous non-small cell lung cancer.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: February 26, 2026
Correction: Durable Response to Nivolumab Combined With Metformin in Advanced Pancreatic Cancer: A Case Report With Seven Years of Follow-Up.
Journal: Cureus
Published: October 20, 2025
Safety and Antitumor Activity of Farletuzumab Ecteribulin in Patients With NSCLC: Phase I Expansion Results.
Journal: JTO clinical and research reports
Published: August 29, 2025
Biomarker analyses to predict benefit of immune checkpoint inhibitors for EGFR-mutated non-small cell lung cancer.
Journal: Cancer treatment and research communications
Published: August 21, 2025
Treatment Outcomes of Stereotactic Body Radiotherapy for Ground Glass Opacity Nodules and Solid Lung Cancer.
Journal: Asia-Pacific journal of clinical oncology
Published: May 30, 2025
Incidence and clinical features of venous thromboembolism in patients with lung cancer in Japan: results from the CS-Lung-003 prospective observational registry study.
Journal: Respiratory investigation
Published: April 02, 2025
Durable Response to Nivolumab Combined With Metformin in Advanced Pancreatic Cancer: A Case Report With Seven Years of Follow-Up.
Journal: Cureus
Published: February 14, 2025
Phase-Ib dose-finding and pharmacokinetic trial of metformin combined with nivolumab for refractory/recurrent solid tumors.
Journal: International journal of clinical oncology
Published: December 26, 2024
A Single-Arm Phase 2 Study of Sotorasib Plus Carboplatin and Pemetrexed in Patients With Advanced Nonsquamous NSCLC With KRAS G12C Mutation (WJOG14821L, SCARLET).
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: October 22, 2024
A phase 1 study of pembrolizumab plus ipilimumab as first-line treatment in Japanese patients with advanced non-small-cell lung cancer.
Journal: Respiratory investigation
Published: October 22, 2024
Clinical impact of hypomagnesemia induced by necitumumab plus cisplatin and gemcitabine treatment in patients with advanced lung squamous cell carcinoma: a subanalysis of the NINJA study.
Journal: Therapeutic advances in medical oncology
Published: October 16, 2024
Last Updated: 09/26/2026